Study: TAVR lowers mortality in high-risk diabetes patients

09/10/2013 | Healio

Transcatheter aortic valve replacement was associated with improved survival in high-risk patients with diabetes and aortic stenosis, according to new research. Mortality at one year was 18% in patients treated with TAVR, compared with 27.4% in those who had surgical aortic valve replacement. The results were presented at the European Society of Cardiology Congress.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD